UniProt ID | RIOK3_HUMAN | |
---|---|---|
UniProt AC | O14730 | |
Protein Name | Serine/threonine-protein kinase RIO3 | |
Gene Name | RIOK3 | |
Organism | Homo sapiens (Human). | |
Sequence Length | 519 | |
Subcellular Localization | Cytoplasm . | |
Protein Description | Involved in regulation of type I interferon (IFN)-dependent immune response which plays a critical role in the innate immune response against DNA and RNA viruses. May act as an adapter protein essential for the recruitment of TBK1 to IRF3. [PubMed: 24807708 Phosphorylates IFIH1 on 'Ser-828' interfering with IFIH1 filament assembly on long dsRNA and resulting in attenuated IFIH1-signaling] | |
Protein Sequence | MDLVGVASPEPGTAAAWGPSKCPWAIPQNTISCSLADVMSEQLAKELQLEEEAAVFPEVAVAEGPFITGENIDTSSDLMLAQMLQMEYDREYDAQLRREEKKFNGDSKVSISFENYRKVHPYEDSDSSEDEVDWQDTRDDPYRPAKPVPTPKKGFIGKGKDITTKHDEVVCGRKNTARMENFAPEFQVGDGIGMDLKLSNHVFNALKQHAYSEERRSARLHEKKEHSTAEKAVDPKTRLLMYKMVNSGMLETITGCISTGKESVVFHAYGGSMEDEKEDSKVIPTECAIKVFKTTLNEFKNRDKYIKDDFRFKDRFSKLNPRKIIRMWAEKEMHNLARMQRAGIPCPTVVLLKKHILVMSFIGHDQVPAPKLKEVKLNSEEMKEAYYQTLHLMRQLYHECTLVHADLSEYNMLWHAGKVWLIDVSQSVEPTHPHGLEFLFRDCRNVSQFFQKGGVKEALSERELFNAVSGLNITADNEADFLAEIEALEKMNEDHVQKNGRKAASFLKDDGDPPLLYDE | |
Overview of Protein Modification Sites with Functional and Structural Information | ||
* ASA = Accessible Surface Area
Locations | Modification | Substrate Peptides & Secondary Structure |
ASA (%) | Reference | Orthologous Protein Cluster |
---|---|---|---|---|---|
8 | Phosphorylation | MDLVGVASPEPGTAA CCCCCCCCCCCCCCC | 27.65 | 23401153 | |
13 | Phosphorylation | VASPEPGTAAAWGPS CCCCCCCCCCCCCCC | 24.68 | 22199227 | |
20 | Phosphorylation | TAAAWGPSKCPWAIP CCCCCCCCCCCCCCC | 42.84 | 22199227 | |
21 | Ubiquitination | AAAWGPSKCPWAIPQ CCCCCCCCCCCCCCC | 47.66 | - | |
101 | Ubiquitination | AQLRREEKKFNGDSK HHHHHHHHHHCCCCC | 58.89 | - | |
102 | Ubiquitination | QLRREEKKFNGDSKV HHHHHHHHHCCCCCE | 47.55 | - | |
107 | Phosphorylation | EKKFNGDSKVSISFE HHHHCCCCCEEEEEE | 36.03 | 29759185 | |
108 | Ubiquitination | KKFNGDSKVSISFEN HHHCCCCCEEEEEEC | 44.75 | 21890473 | |
108 (in isoform 2) | Ubiquitination | - | 44.75 | 21890473 | |
108 (in isoform 1) | Ubiquitination | - | 44.75 | 21890473 | |
110 | Phosphorylation | FNGDSKVSISFENYR HCCCCCEEEEEECCE | 19.09 | 22210691 | |
112 | Phosphorylation | GDSKVSISFENYRKV CCCCEEEEEECCEEE | 20.99 | 25159151 | |
116 | Phosphorylation | VSISFENYRKVHPYE EEEEEECCEEECCCC | 12.47 | 25159151 | |
122 | Phosphorylation | NYRKVHPYEDSDSSE CCEEECCCCCCCCCC | 19.93 | 23927012 | |
125 | Phosphorylation | KVHPYEDSDSSEDEV EECCCCCCCCCCCCC | 27.70 | 23927012 | |
127 | Phosphorylation | HPYEDSDSSEDEVDW CCCCCCCCCCCCCCC | 39.31 | 23927012 | |
128 | Phosphorylation | PYEDSDSSEDEVDWQ CCCCCCCCCCCCCCC | 54.80 | 23927012 | |
142 | Phosphorylation | QDTRDDPYRPAKPVP CCCCCCCCCCCCCCC | 35.90 | 28064214 | |
146 (in isoform 1) | Ubiquitination | - | 49.59 | 21890473 | |
146 (in isoform 2) | Ubiquitination | - | 49.59 | 21890473 | |
146 | Ubiquitination | DDPYRPAKPVPTPKK CCCCCCCCCCCCCCC | 49.59 | 21906983 | |
150 | Phosphorylation | RPAKPVPTPKKGFIG CCCCCCCCCCCCCCC | 48.23 | 30576142 | |
152 | Ubiquitination | AKPVPTPKKGFIGKG CCCCCCCCCCCCCCC | 68.92 | - | |
158 | Ubiquitination | PKKGFIGKGKDITTK CCCCCCCCCCCCCCC | 58.95 | - | |
160 | Ubiquitination | KGFIGKGKDITTKHD CCCCCCCCCCCCCCC | 49.82 | - | |
165 | Ubiquitination | KGKDITTKHDEVVCG CCCCCCCCCCEEECC | 40.17 | - | |
197 | Ubiquitination | DGIGMDLKLSNHVFN CCCCCCHHHHHHHHH | 45.68 | - | |
207 (in isoform 1) | Ubiquitination | - | 37.31 | 21890473 | |
207 | Ubiquitination | NHVFNALKQHAYSEE HHHHHHHHHHCCCHH | 37.31 | 21890473 | |
207 (in isoform 2) | Ubiquitination | - | 37.31 | 21890473 | |
212 | Phosphorylation | ALKQHAYSEERRSAR HHHHHCCCHHHHHHH | 33.49 | 28348404 | |
217 | Phosphorylation | AYSEERRSARLHEKK CCCHHHHHHHHHHHH | 24.78 | 27282143 | |
231 | Ubiquitination | KEHSTAEKAVDPKTR HCCCCHHHHCCHHHH | 51.77 | - | |
236 | Ubiquitination | AEKAVDPKTRLLMYK HHHHCCHHHHHHHHH | 41.64 | - | |
247 | Phosphorylation | LMYKMVNSGMLETIT HHHHHHHCCCHHHHH | 17.73 | 23532336 | |
281 | Ubiquitination | EDEKEDSKVIPTECA CCCCCCCCCCCHHHH | 57.41 | - | |
290 (in isoform 2) | Ubiquitination | - | 24.08 | 21890473 | |
290 | Ubiquitination | IPTECAIKVFKTTLN CCHHHHHHHHHHHHH | 24.08 | 21890473 | |
290 (in isoform 1) | Ubiquitination | - | 24.08 | 21890473 | |
293 | Ubiquitination | ECAIKVFKTTLNEFK HHHHHHHHHHHHHHH | 43.52 | - | |
294 | Phosphorylation | CAIKVFKTTLNEFKN HHHHHHHHHHHHHHC | 25.67 | 30622161 | |
295 | Phosphorylation | AIKVFKTTLNEFKNR HHHHHHHHHHHHHCC | 28.33 | 30622161 | |
300 (in isoform 2) | Ubiquitination | - | 44.91 | 21890473 | |
300 (in isoform 1) | Ubiquitination | - | 44.91 | 21890473 | |
300 | Ubiquitination | KTTLNEFKNRDKYIK HHHHHHHHCCCCCCC | 44.91 | 21890473 | |
304 | Ubiquitination | NEFKNRDKYIKDDFR HHHHCCCCCCCCCCC | 45.71 | - | |
307 | Ubiquitination | KNRDKYIKDDFRFKD HCCCCCCCCCCCCHH | 48.43 | - | |
318 (in isoform 2) | Ubiquitination | - | 49.96 | 21890473 | |
318 (in isoform 1) | Ubiquitination | - | 49.96 | 21890473 | |
318 | Ubiquitination | RFKDRFSKLNPRKII CCHHHHHHCCHHHHH | 49.96 | 21890473 | |
348 | Phosphorylation | RAGIPCPTVVLLKKH HCCCCCCHHHHCCCC | 29.93 | 23403867 | |
376 | Ubiquitination | APKLKEVKLNSEEMK CCCCCEECCCHHHHH | 42.94 | - | |
452 (in isoform 1) | Ubiquitination | - | 53.10 | 21890473 | |
452 | Ubiquitination | NVSQFFQKGGVKEAL CHHHHHHCCCHHHHH | 53.10 | 21890473 | |
456 (in isoform 1) | Ubiquitination | - | 40.31 | 21890473 | |
456 | Ubiquitination | FFQKGGVKEALSERE HHHCCCHHHHHCHHH | 40.31 | 21890473 | |
502 | Ubiquitination | HVQKNGRKAASFLKD HHHHHCHHHHHHHCC | 50.10 | - | |
505 | Phosphorylation | KNGRKAASFLKDDGD HHCHHHHHHHCCCCC | 35.65 | 30576142 | |
505 (in isoform 2) | Ubiquitination | - | 35.65 | 21890473 | |
508 (in isoform 1) | Ubiquitination | - | 52.33 | 21890473 | |
508 | Ubiquitination | RKAASFLKDDGDPPL HHHHHHHCCCCCCCC | 52.33 | 2190698 | |
517 | Phosphorylation | DGDPPLLYDE----- CCCCCCCCCC----- | 26.21 | 18083107 |
Modified Location | Modified Residue | Modification | Function | Reference | ||
---|---|---|---|---|---|---|
Oops, there are no descriptions of PTM sites of RIOK3_HUMAN !! |
* Distance = the distance between SAP position and PTM sites.
Modified Location | Modification | Variant Position (Distance <= 10) |
Residue Change | SAP | Related Disease | Reference |
---|---|---|---|---|---|---|
Oops, there are no SNP-PTM records of RIOK3_HUMAN !! |
Interacting Protein | Gene Name | Interaction Type | PPI Reference | Domain-Domain Interactions |
---|---|---|---|---|
RUVB2_HUMAN | RUVBL2 | physical | 17353931 | |
SSRD_HUMAN | SSR4 | physical | 17353931 | |
FBRL_HUMAN | FBL | physical | 17353931 | |
PSB1_HUMAN | PSMB1 | physical | 17353931 | |
PRS6B_HUMAN | PSMC4 | physical | 17353931 | |
MAGA6_HUMAN | MAGEA6 | physical | 17353931 | |
SPT6H_HUMAN | SUPT6H | physical | 26496610 | |
ZMAT3_HUMAN | ZMAT3 | physical | 26496610 | |
OSBL5_HUMAN | OSBPL5 | physical | 26496610 |
Kegg Disease | ||||||
---|---|---|---|---|---|---|
There are no disease associations of PTM sites. | ||||||
OMIM Disease | ||||||
There are no disease associations of PTM sites. | ||||||
Kegg Drug | ||||||
There are no disease associations of PTM sites. | ||||||
DrugBank | ||||||
There are no disease associations of PTM sites. |
loading...
Phosphorylation | |
Reference | PubMed |
"A quantitative atlas of mitotic phosphorylation."; Dephoure N., Zhou C., Villen J., Beausoleil S.A., Bakalarski C.E.,Elledge S.J., Gygi S.P.; Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT TYR-122; SER-127 ANDSER-128, AND MASS SPECTROMETRY. |